Showing results (21-30 of 295) with videos related to
Sort By:
Pageof 30
Journal of the National Comprehensive Cancer Network : JNCCN|September 3, 2021
Quantifying Withdrawal of Consent, Loss to Follow-Up, Early Drug Discontinuation, and Censoring in Oncology TrialsBrooke E Wilson, Michelle B Nadler, Alexandra Desnoyers, et al.Cancer Treatment Reviews|March 2, 2021
Fragility index of trials supporting approval of anti-cancer drugs in common solid tumoursAlexandra Desnoyers, Brooke E Wilson, Michelle B Nadler, et al.Cancer Immunology, Immunotherapy : CII|December 23, 2019
The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studiesBrooke E Wilson, Bertrand Routy, Adnan Nagrial, et al.Frontiers in Genetics|April 17, 2023
Exploring immune interactions in triple negative breast cancer: IL-1β inhibition and its therapeutic potentialBrooke E Wilson, Qiang Shen, David W Cescon, et al.European Journal of Cancer (Oxford, England : 1990)|June 24, 2009
Clinical benefit in oncology trials: is this a patient-centred or tumour-centred end-point?Pavlo Ohorodnyk, Elizabeth A Eisenhauer, Christopher M BoothEuropean Urology|March 16, 2021
Untangling the PROfound Trial for Advanced Prostate Cancer: Is There Really a Role for Olaparib?Daniel H Kwon, Christopher M Booth, Vinay PrasadNature Reviews. Clinical Oncology|February 1, 2019
Real-world data: towards achieving the achievable in cancer careChristopher M Booth, Safiya Karim, William J MackillopJournal of Global Oncology|December 16, 2017
Oral Morphine Use in South India: A Population-Based StudyM R Rajagopal, Safiya Karim, Christopher M BoothObstetrics and Gynecology|November 2, 2005
Pasteurella multocida bacteremia and tuboovarian abscessKerry A Myckan, Christopher M Booth, Eva MocarskiFrontiers in Oncology|June 26, 2024
Hemophagocytic lymphohistiocytosis/cytokine release syndrome secondary to neoadjuvant pembrolizumab for triple-negative breast cancer: a case studyLaura Patton, Bethany Monteith, Paul Heffernan, et al.Pageof 30